IP Library › Assignment 044451/0189
Patent Assignment
Reel/Frame 044451/0189

Assignment of Assignor's Interest

Recorded: 2017-12-20 Pages: 21
Assignors
CONCINO, MICHAEL F.
Executed: 2013-07-25
CALIAS, PERICLES
Executed: 2013-07-18
PAN, JING
Executed: 2013-07-18
HOLMES, KEVIN
Executed: 2013-07-18
MARTINI, PAOLO
Executed: 2013-07-24
ROMASHKO, ALLA
Executed: 2013-07-25
MEIYAPPAN, MUTHURAMAN
Executed: 2013-07-18
ZHANG, BOHONG
Executed: 2013-07-18
ISKENDERIAN, ANDREA
Executed: 2013-07-25
LUNDBERG, DIANNA
Executed: 2013-07-18
NORTON, ANGELA
Executed: 2013-07-18
STRACK-LOGUE, BETTINA
Executed: 2013-07-25
YAN, HUANG
Executed: 2013-07-18
ALESSANDRINI, MARY
Executed: 2013-07-18
PFEIFER, RICHARD
Executed: 2013-07-18
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Therapeutic Fusion Protein Comprising an Alpha-N-Acetylglucosaminidase and a Lysosomal Targeting Moiety
Application: 15/715,748 →
Publication: US 2018/0085438
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 15, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 061447/0760 →